search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EQUINE VETERINARY EDUCATION / AE / SEPTEMBER 2018


499


Horizontal Transmission


-Semen collection (contaminated artificial vagina & phantom)


-Personnel -Teaser -Fomites


-Masturbation


Stallions Colts


No carrier state in mares, geldings and prepubertal colts


Natural Reservoir of EAV Carrier Stallion


Venereal Transmission


-Natural breeding -Artificial breeding


Raw semen Chilled semen Frozen semen


EVA Outbreak Horizontal Transmission


-Aerosolisation of respiratory secretion


-Direct contact with virus in placental fluids, secretions & fetal tissues


Mare Pregnant and non-pregnant mares, geldings, <6 month-old foals Fig 1: Transmission and outcome of equine viral arteritis (EAV) infection in equine populations. Clinical signs and the disease


The range and severity of clinical signs displayed by EAV acutely infected horses depend on a variety of factors, including the genetics, age, physical condition of the horses, challenge dose, route of infection, viral strain, and environmental conditions (Vaala et al. 1992; McCollum and Timoney 1998; Moore et al. 2002). Although there is only one known serotype of EAV (McCollum 1969a), there is


significant variation in virulence phenotype between EAV field strains, and based on the clinical severity of the disease during natural outbreaks, EAV field strains could be segregated into viruses that cause moderate to severe disease (e.g. EAV KY84, EAV AZ87, EAV IL93 and EAV PA96), moderate disease (EAV PA76, and EAV KY77) mild disease (e.g. EAV SWZ64, EAV AUT68, EAV IL94 and EAV CA97), and asymptomatic infection (e.g. EAV KY63, and EAV CA95) (Balasuriya et al. 1995, 1997; MacLachlan et al. 1996; McCollum and Timoney 1998; Moore et al. 2002, 2003a,b; Zhang et al. 2008, 2010a, 2012; Pronost et al. 2010; Vairo et al. 2012, 2014). The highly virulent horse-adapted Bucyrus strain of EAV (VBS, which causes high mortality in healthy mature horses) and the associated pathology is not representative of that caused by field strains of the virus


isolated to date; it is best regarded as a laboratory derived experimental virus variant. While the vast majority of EAV infections are inapparent


(or subclinical), some acutely infected animals may develop a wide range of clinical signs. After an incubation period of 2–14 days (6–8 days after venereal exposure), EAV infected horses can develop a wide combination of clinical signs, including respiratory disease and reproductive consequences (Fig 2).


Acute infection Acutely infected animals may develop an influenza–like syndrome, with fever, depression, anorexia, dependent oedema (scrotum, mammary gland, ventral trunk, and limbs), stiffness of gait, conjunctivitis and rhinitis with nasal and ocular discharge, periorbital and/or supraorbital oedema, respiratory distress, skin rash (localised to the sides of the neck, face, or widespread), and leukopenia (Doll et al. 1957b; McCollum et al. 1971, 1995; McCollum and Timoney 1984; Timoney 1984; Timoney and McCollum 1993; Glaser et al. 1996, 1997; Balasuriya et al. 1999b, 2002a) (Fig 2). Pyrexia (of up to 41°C) may persist for 2–9 days (McCollum et al. 1988; MacLachlan et al. 1996; Balasuriya et al. 2007; Go et al. 2012b; Zhang et al. 2012; Campos et al. 2014). Other less frequently


© 2016 EVJ Ltd


-Fomites -Personnel


Establishment of persistent infection


Abortion Weak foals


Congenital infections


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84